Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5K Hold
364
– – ﹤0.01% 373
2026
Q2
$19.1K Hold
364
– – ﹤0.01% 347
2026
Q1
$20.1K Hold
364
– – ﹤0.01% 350
2025
Q4
$17.9K Hold
364
– – ﹤0.01% 305
2025
Q3
$15.7K Sell
364
-895
-71% -$35K ﹤0.01% 340
2025
Q2
$48.3K Buy
+1,259
New +$48.1K ﹤0.01% 247
2021
Q2
– Sell
-5,339
Closed -$238K – 195
2021
Q1
$238K Sell
5,339
-76,956
-94% -$3.49M 0.03% 175
2020
Q4
$3.79M Sell
82,295
-5,518
-6% -$253K 0.38% 68
2020
Q3
$4.13M Buy
87,813
+14,884
+20% +$746K 0.47% 53
2020
Q2
$3.72M Buy
72,929
+10,204
+16% +$524K 0.44% 66
2020
Q1
$2.97M Buy
62,725
+16,168
+35% +$862K 0.41% 70
2019
Q4
$2.74M Buy
46,557
+6,507
+16% +$362K 0.31% 81
2019
Q3
$2.14M Buy
40,050
+2,457
+7% +$126K 0.28% 83
2019
Q2
$1.88M Buy
37,593
+1,279
+4% +$64.2K 0.25% 87
2019
Q1
$1.9M Buy
36,314
+946
+3% +$47.3K 0.26% 84
2018
Q4
$1.69M Buy
35,368
+15,557
+79% +$766K 0.26% 84
2018
Q3
$995K Buy
19,811
+753
+4% +$38.3K 0.14% 100
2018
Q2
$960K Buy
+19,058
New +$960K 0.14% 100

Other funds holding GSK

Alerus Financial's GSK Position: Q3 2026 in Review

Alerus Financial held its GSK (GSK) position steady in Q3 2026 at 364 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Alerus Financial first reported a position in GSK in Q2 2018 and has held it in 18 quarters since. The position peaked at $4.13M in Q3 2020. 990 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Alerus Financial held 364 shares of GSK worth $17.5K as of Q3 2026.
  • Alerus Financial left its GSK share count unchanged in Q3 2026.
  • GSK made up ﹤0.01% of Alerus Financial's portfolio in Q3 2026, its #373 holding.
  • Alerus Financial first reported a position in GSK in Q2 2018 and has held it in 18 quarters since.
  • Alerus Financial's GSK position peaked at $4.13M in Q3 2020.
  • 990 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Alerus Financial's 13F filing for Q3 2026, filed 9 Nov 2026.